Abstract
Although systemic chemotherapy has been recognized as a standard treatment for gastric cancer with synchronous hepatic metastasis, the survival benefit of the therapy is still unsatisfactory. On the other hand, the local effect of intra-hepatic arterial chemotherapy (HAIC) is very high, and HAIC combined with systemic chemotherapy and surgery will be an effective therapy for selected patients. Here, we report a 39-year-old female case with advanced gastric cancer and synchronous liver metastasis. She has been treated with systemic chemotherapy, HAIC, and two operations. She has survived for 33 months now. The HAIC therapy will be a promising therapy in combination with systemic chemotherapy and/or surgery for gastric cancer with synchoromous liver metastasis.
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biopsy
-
Cisplatin / administration & dosage
-
Cisplatin / therapeutic use
-
Doxorubicin / administration & dosage
-
Doxorubicin / therapeutic use
-
Female
-
Fluorouracil / administration & dosage
-
Fluorouracil / therapeutic use
-
Gastroscopy
-
Humans
-
Infusions, Intra-Arterial
-
Liver Neoplasms / diagnostic imaging
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / secondary*
-
Liver Neoplasms / surgery
-
Male
-
Middle Aged
-
Stomach Neoplasms / diagnostic imaging
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / pathology*
-
Stomach Neoplasms / surgery
-
Tomography, X-Ray Computed
Substances
-
Doxorubicin
-
Cisplatin
-
Fluorouracil